0
0
Invasive Group B Streptococcus (iGBS) infection in early infancy is linked to a significantly higher risk of developing psychiatric disorders extending into adolescence, according to a large population-based Danish study published in 2025. The study found that infants who suffered from iGBS, particularly those with meningitis, had a 41% increased risk of psychiatric disorders compared to unaffected peers, underscoring the long-term mental health impact of this neonatal infection. Additional factors such as premature birth, maternal gestational diabetes, and low maternal education were shown to further elevate this risk, highlighting the need for preventive and supportive measures in vulnerable populations.
Key Study Findings and Background
The Danish national cohort study included 1,548 infants diagnosed with invasive Group B Streptococcus disease within the first three months of life between 1997 and 2020, matched with 15,345 control infants by sex, birth year, and gestational age. Approximately 88% of affected infants had sepsis, and 12% had meningitis. The study followed children until early adulthood in 2022 to assess the cumulative incidence of various psychiatric disorders.
The cumulative incidence of any psychiatric disorder was 21.1% in the iGBS-affected group versus 16.2% in controls over the observation period. Psychiatric disorders with elevated risks included anxiety, obsessive-compulsive disorder (OCD), autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), intellectual disabilities, nervous and stress-related disorders, and behavioral disorders. The risk was notably higher among infants who experienced meningitis (30.1%) compared to those with sepsis alone (20.0%).
Expert Commentary and Context
Dr. Malene Risager Lykke, the lead author and clinical epidemiologist at Aarhus University Hospital, emphasized the clinical significance: “Our findings suggest that effective prevention of invasive Group B Streptococcus could not only reduce neonatal mortality but also decrease the long-term burden of psychiatric disorders stemming from these infections”.
Group B Streptococcus (Streptococcus agalactiae) is a leading cause of neonatal infection globally, responsible for sepsis and meningitis during early infancy. It is transmitted from mother to child mainly during delivery, often unnoticed until severe symptoms appear in the infant. Worldwide, it affects approximately 319,000 infants annually, with high mortality rates in many regions and significant neurodevelopmental consequences for survivors.
Public Health Implications
The study suggests an urgent need for continued efforts in screening and preventing maternal GBS colonization during pregnancy as a strategy to reduce adverse neuropsychiatric outcomes in children. Preventive practices might include maternal intrapartum antibiotic prophylaxis and potentially the development or broader use of GBS vaccines currently under research. Furthermore, infants who survive iGBS infections, especially meningitis, should receive long-term developmental and psychiatric monitoring to identify and address emerging challenges early.
Considering these neuropsychiatric consequences also brings focus to families and caregivers. Birthing parents of iGBS-affected infants show a slight but significant increase in depression and anxiety, highlighting the need for mental health support alongside neonatal care.
Limitations and Balanced Perspective
While the Danish register-based study provides robust longitudinal data, its findings may have contextual limitations due to the population’s geographic and socioeconomic characteristics, which may differ from global regions with higher iGBS mortality or different healthcare access. Also, psychiatric diagnoses depend on registry data, which might underrepresent subclinical or undiagnosed cases. Additional studies in diverse populations and longer follow-ups could enhance understanding.
There are some conflicting data from other studies showing variable neurodevelopmental outcomes in iGBS survivors, necessitating cautious interpretation. However, this study’s large size and comprehensive national data support a clear association between early-life iGBS infection and later psychiatric risk.
Practical Advice for Readers
Parents and caregivers should be informed about the importance of maternal GBS screening during pregnancy and the signs of iGBS infection in newborns. Early treatment of iGBS improves survival and potentially mitigates long-term complications. Healthcare providers should consider follow-up evaluations focusing on neurodevelopment and mental health for children with a history of iGBS and provide supportive resources for affected families. Awareness of the risk factors such as prematurity and maternal health conditions can aid in targeted monitoring.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
